Skip to content

Laryngeal Mask Airway (LMA) Complication in Children

Retrospective Investigation of Perioperative Upper Airway Complications After Anesthesia Using Supraglottic Airway Devices in Children: Comparison of Desflurane and Sevoflurane

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02644226
Enrollment
3528
Registered
2015-12-31
Start date
2015-11-30
Completion date
2016-01-31
Last updated
2016-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Mask Airway

Brief summary

Desflurane is known to be the most pungent of the currently used volatile anesthetics. The investigators tried to find out if desflurane increases the incidence of perioperative upper airway complications in infants and children undergoing general anesthesia using supraglottic airways compared to sevoflurane.

Detailed description

The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents.

Interventions

OTHERSevoflurane

The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane as maintenance agents.

OTHERDesflurane

The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using desflurane as maintenance agents.

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents

Exclusion criteria

* Tracheal intubation

Design outcomes

Primary

MeasureTime frame
Occurrence of desaturationintraoperative
Occurrence of Laryngospasmintraoperative
Occurrence of Coughintraoperative

Secondary

MeasureTime frame
Occurrence of Laryngospasmthrough study completion, an average of 1 day
Occurrence of desaturationthrough study completion, an average of 1 day
Occurrence of Coughthrough study completion, an average of 1 day

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026